Foundry Partners, LLC Pacira Bio Sciences, Inc. Transaction History

Foundry Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$54.64 - $61.3 $4.89 Million - $5.48 Million	-89,419 Closed	0 $0
Q2 2021 Jul 23, 2021	SELL	$59.18 - $69.99 $134,397 - $158,947	-2,271 Reduced 2.48%	89,419 $5.43 Million
Q1 2021 May 12, 2021	SELL	$59.31 - $78.82 $187,004 - $248,519	-3,153 Reduced 3.32%	91,690 $6.43 Million
Q4 2020 Feb 04, 2021	BUY	$50.47 - $66.26 $37,398 - $49,098	741 Added 0.79%	94,843 $5.68 Million
Q3 2020 Oct 23, 2020	SELL	$51.97 - $63.0 $74,109 - $89,838	-1,426 Reduced 1.49%	94,102 $5.66 Million
Q2 2020 Aug 03, 2020	BUY	$30.8 - $52.47 $2.94 Million - $5.01 Million	95,528 New	95,528 $5.01 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.